Cordis Wins Another Round in Patent Infringement Case

Cordis Corp. said a Delaware federal judge has granted its motion for final judgment against Boston Scientific Corp. and Medtronic, in their cases involving the original Palmaz balloon expandable stent patent.

Miami Lakes, FL-based Cordis, a Johnson & Johnson company, had asked US District Court Judge Sue Robinson to reinstate the verdicts that Cordis won in 2000, plus accrued interest.

In those cases, Cordis won $324 million against Boston Scientific of Natick, MA, and $271 million against Minneapolis, MN-based Medtronic, before interest.

Following appeals, both cases were retried in March 2005, with Cordis winning again. In January 2007, a federal circuit court in Washington, D.C., upheld the jury verdicts. At that time, Cordis said it would ask the Delaware judge to reinstate damages.

The case relates to Medtronic’s GFX and Microstent II and Boston’s NIR stent.

In her order, the judge indicated she would enter final judgment on Sept. 30.

Boston Scientific said in a press release that it no longer sells the NIR stent. However, it announced it plans to appeal the decision.

Medtronic did not respond to requests for comment.